The progression of cancers and neurodegenerative disorders is largely defined by a set of
molecular determinants that are either complementarily deregulated, or share remarkably …

From transcription, to transport, storage, and translation, RNA depends on association with
different RNA‐binding proteins (RBPs). Methods based on next‐generation sequencing and …

The combination of high-throughput sequencing and in vivo crosslinking approaches leads
to the progressive uncovering of the complex interdependence between cellular …

Disease epidemiology during ageing shows a transition from cancer to degenerative chronic
disorders as dominant contributors to mortality in the old. Nevertheless, it has remained …

Cancer is one of the most common causes of death; in parallel, the incidence and
prevalence of central nervous system diseases are equally high. Among neurodegenerative …

The embryonic ectoderm development (EED) is a core component of the polycomb-
repressive complex 2 (PRC2) whose mutations are linked to neurodevelopmental …

Cells are constantly exposed to DNA damaging insults. To protect the organism, cells
developed a complex molecular response coordinated by P53, the master regulator of DNA …

Neurodegenerative disorders and cancer may appear unrelated illnesses. Yet,
epidemiologic studies indicate an inverse correlation between their respective incidences …

Objective To systematically review and qualitatively evaluate epidemiological evidence on
associations between Parkinson's disease (PD) and cancer via meta-analysis. Data sources …

Simple Summary This narrative review first describes from several points of view the
complex interrelationship between cancer and neurodegeneration, with special attention to …